My goal as a physician is to provide personalized care for my patients, tailoring state-of-the-art therapy to their individual situations, and providing them access to cutting-edge clinical trials. I believe that the care of my patients extends well beyond just focusing on the optimal therapy of their cancer; my approach is to treat patients as an individual, addressing all the social, emotional and psychological issues that arise secondary to a cancer diagnosis.
Work and Credentials:
Primary Location
Position
Medical Oncologist
Board Certification
Medical Oncology and Hematology
Fellowship
Cleveland Clinic Taussig Cancer Institute
Internship
Case Western Reserve University, Cleveland, OH
Residency
University Hospitals Cleveland Medical Center
Medical School
Pravara Institute of Medical Sciences, Ahmednagar, India
College
Pravara Institute of Medical Sciences, Ahmednagar, India
Special Interests
Breast Cancer
Shruti Tiwari, MD, is board certified in Medical Oncology and Hematology. She is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Medical Association.
As a medical oncologist, Dr. Tiwari specializes in the treatment and management of breast cancer through the use of chemotherapy, hormonal therapy, and targeted treatments. As a breast specialist, Dr. Tiwari works with a multidisciplinary team, which includes breast surgeons, radiation oncologists, nurse practitioners, nurse navigators, genetic counselors, clinical trials and research, dietitians and more.
Dr. Tiwari received her medical degree from the Pravara Institute of Medical Sciences in Ahmednagar, India. She then completed residency training in internal medicine at the University Hospitals Cleveland Medical Center via the American Board of Internal Medicine Physician Scientist track. Finally, she completed a fellowship in hematology/oncology at the Cleveland Clinic Taussig Cancer Institute. After completing her fellowship, she served as Assistant Professor of Medicine and Oncology at Georgetown University, and Medstar Georgetown cancer institute. Her research interests include exploring novel targeted treatments for HER2 positive breast cancer, triple negative breast cancer, health disparities, and patient reported outcomes. Additionally, Dr. Tiwari conducted research evaluating clinical outcomes in very small HER2 positive tumors, exploring the need for chemotherapy treatment in these patients. She is currently involved in evaluating the role of circulating tumor DNA in treatment and monitoring of HER2 positive and triple negative breast cancer. She also serves as principal investigator on multiple breast cancer clinical trials and is very motivated to provide cutting edge and compassionate care to her patients.
Dr. Tiwari is published in numerous peer-reviewed journals and has presented her work at national conferences on various occasions. Dr. Tiwari has been named a Top Doctor by the Washingtonian and Northern Virginia Magazine.
In her spare time she loves to spend time with her husband and two boys. She also enjoys being outdoors and spends time gardening, hiking and traveling.
Clinical Trials (1)
Clinical Trial LAE205INT3101
A Phase Ib/III Study to Evaluate the Efficacy and Safety of Afuresertib Plus Fulvestrant in Patients with Locally Advanced or Metastatic HR+/HER2- Breast Cancer Who Failed Standard of Care Therapies
